1. Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014; 29:1–23.
Article
2. Das De S, Setiobudi T, Shen L, Das De S. A rational approach to management of alendronate-related subtrochanteric fractures. J Bone Joint Surg Br. 2010; 92:679–686.
Article
3. Borrelli J Jr, Lane J, Bukata S, Egol K, Takemoto R, Slobogean G. Atypical femur fractures. J Orthop Trauma. 2014; 28:S36–S42.
Article
4. Visekruna M, Wilson D, McKiernan FE. Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab. 2008; 93:2948–2952.
Article
5. Weil YA, Rivkin G, Safran O, Liebergall M, Foldes AJ. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use. J Trauma. 2011; 71:186–190.
Article
6. Egol KA, Park JH, Rosenberg ZS, Peck V, Tejwani NC. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails. Clin Orthop Relat Res. 2014; 472:2728–2734.
Article
7. Bonifacio L, Syson P. Construct failure in an atypical femoral fracture treated with intramedullary nailing: a case report. Malays Orthop J. 2014; 8:82–84.
Article
8. Iwamoto J, Takeda T. Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report. J Orthop Sci. 2002; 7:707–712.
Article
9. Kitajima I, Tachibana S, Mikami Y, Mori T, Hirota Y, Nakamichi K. Insufficiency fracture of the femoral neck after intramedullary nailing. J Orthop Sci. 1999; 4:304–306.
Article
10. Yang KH, Min BW, Ha YC. Atypical femoral fracture: 2015 position statement of the Korean society for bone and mineral research. J Bone Metab. 2015; 22:87–91.
Article